Brief: Orthocell Applies For Australian Market Approval For Smrtgraft Tendon Repair Device
11/06/2024 02:49
June 11 (Reuters) - Orthocell Ltd OCC.AX :
* APPLIED TO THERAPEUTIC GOOD ADMINISTRATION FOR AUSTRALIAN
MARKET
APPROVAL FOR ITS SMRTGRAFT TENDON REPAIR DEVICE
Source text for Eikon: ID:nASX6zXW2n
Further company coverage: OCC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense